A detailed history of Two Sigma Investments, LP transactions in Compass Pathways PLC stock. As of the latest transaction made, Two Sigma Investments, LP holds 229,184 shares of CMPS stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
229,184
Previous 348,544 34.25%
Holding current value
$1.96 Million
Previous $2.98 Million 34.24%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-119,360 Reduced 34.25%
229,184 $1.96 Million
Q2 2024

Aug 14, 2024

BUY
N/A
186,421 Added 114.99%
348,544 $2.98 Million
Q1 2024

May 15, 2024

BUY
N/A
87,792 Added 118.11%
162,123 $1.38 Million
Q4 2023

Feb 14, 2024

BUY
N/A
74,331 New
74,331 $634,000
Q2 2023

Aug 14, 2023

SELL
$7.79 - $10.69 $368,311 - $505,423
-47,280 Reduced 78.5%
12,951 $110,000
Q1 2023

May 15, 2023

SELL
$7.32 - $10.85 $646,275 - $957,935
-88,289 Reduced 59.45%
60,231 $598,000
Q4 2022

Feb 14, 2023

SELL
$7.84 - $11.68 $339,370 - $505,592
-43,287 Reduced 22.57%
148,520 $1.19 Million
Q3 2022

Nov 14, 2022

SELL
$10.73 - $20.07 $30,247 - $56,577
-2,819 Reduced 1.45%
191,807 $2.06 Million
Q2 2022

Aug 15, 2022

SELL
$6.76 - $14.18 $1.76 Million - $3.7 Million
-260,863 Reduced 57.27%
194,626 $2.11 Million
Q1 2022

May 16, 2022

BUY
$11.13 - $23.04 $883,599 - $1.83 Million
79,389 Added 21.11%
455,489 $5.87 Million
Q4 2021

Feb 14, 2022

BUY
$21.81 - $48.96 $7.62 Million - $17.1 Million
349,337 Added 1305.3%
376,100 $8.31 Million
Q3 2021

Nov 15, 2021

BUY
$29.03 - $38.62 $776,929 - $1.03 Million
26,763 New
26,763 $799,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.